Document is current
Any future updates will be listed below
-
Authors
Courtois, Anoïsia
Marié, Constance
Fouquet, Gregory
Diouf, Momar
Esparteiro, Damien
Ducournau, Gérard
Marticho, Léa
Naassila, Mickaël
Nguyen-Khac, Eric
Marcq, Ingrid https://orcid.org/0000-0002-4031-224X
- License Information
-
More Information
Article History
Received: 11 June 2025
Revised: 9 January 2026
Accepted: 12 January 2026
First Online: 25 January 2026
Declarations
:
: Patients are part of the CHIEF cohort (French National Cohort of HCC patients, NCT04348838). All included patients provided signed and informed consent for the anonymous use of their clinical and biological data. The study was approved by local ethics committees: “Comité de Protection des Personnes Sud-Est IV” (Agence Régionale de santé d’Auvergne-Rhône-Alpes). The study is classified as MR01 issued by la Commission Nationale de l’Informatique et des Libertés (CNIL).
: The authors declare no competing interests.
: The clinical trial number of the CHIEF cohort is NCT04348838, registered under registration number 19.04.15.41412 by the “Comité de Protection des Personnes Sud-Est IV” (RCB ID: 2019-A00679-48).
